#AIEye #Podcast Episode 487: AWS (NasdaqGS: $AMZN) Announces Five New ML Services at re:Invent Conference and Baidu (NasdaqGS: $BIDU) Named Leader in #AI-Patent Applications in China for 2020; #artificialintelligence

#AIEye #Podcast Episode 487: AWS (NasdaqGS: $AMZN) Announces Five New ML Services at re:Invent Conference and Baidu (NasdaqGS: $BIDU) Named Leader in #AI-Patent Applications in China for 2020; #artificialintelligence

 

Global AI in Commerce Market to Reach $1.977 Billion by 2027

 

Point Roberts WA, Vancouver BC – December 2, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/120220-AI-Eye.mp3

 

Read this in full at

https://www.investorideas.com/news/2020/artificial-intelligence/12021AMZN-BIDU.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (NasdaqGS:AMZN) (NasdaqGS:BIDU)

 

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced five new machine learning services – Amazon Monitron, Amazon Lookout for Equipment, AWS Panorama Appliance, AWS Panorama SDK, and Amazon Lookout for Vision – to “help industrial and manufacturing customers embed intelligence in their production processes in order to improve operational efficiency, quality control, security, and workplace safety.” This announcement was made at the AWS re:Invent virtual conference today. Briefly, according to the press release, Monitron and Lookout enable machine learning-powered predictive maintenance, and Panorama “uses computer vision to improve industrial operations and workplace safety.” Swami Sivasubramanian, Vice President of Amazon Machine Learning for AWS, explained:

 

"Industrial and manufacturing customers are constantly under pressure from their shareholders, customers, governments, and competitors to reduce costs, improve quality, and maintain compliance. These organizations would like to use the cloud and machine learning to help them automate processes and augment human capabilities across their operations, but building these systems can be error prone, complex, time consuming, and expensive. We’re excited to bring customers five new machine learning services purpose-built for industrial use that are easy to install, deploy, and get up and running quickly and that connect the cloud to the edge to help deliver the smart factories of the future for our industrial customers."

 

Baidu, Inc. (NasdaqGS:BIDU), according to a recent study published by two units of China's Ministry of Industry and Information Technology (MIIT), “holds the most AI-related patents and has filed the most AI-related patent applications of any company or organization in China.” As of October this year, the company has filed a total of 9,364 AI-related patent applications, of which it has been granted 2,682. These cover an array of sub-fields of AI, including deep learning, autonomous driving, and NLP and intelligent speech technologies.

 

Global AI in Commerce Market to Reach $1.977 Billion by 2027

 

A report published by Data Bridge Market Research finds that the global AI in Commerce market will grow at an average annual rate of 7.87 percent from 2020-2027 and reach $1.977 billion by 2027. An excerpt from the report’s description explains:

 

Commerce AI business is developing at a firm movement and is estimated to be propelled by online retailers in e-commerce purchasing, style stores, and repository mechanization. The impeccable keen sightedness of AI in enterprises will transform the purchasing practice, decision building will be responsive and most of the methods will be automated. Also, upcoming technologies like big data will moreover heighten the extent of the market.

 

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

#CryptoCorner #Podcast Episode 484: Visa (NYSE: $V) and BlockFi Partner for Credit Card with BTC Rewards, HIVE (TSXV: $HIVE.V) Reports Q2 Results

 #CryptoCorner #Podcast Episode 484: Visa (NYSE: $V) and BlockFi Partner for Credit Card with BTC Rewards, HIVE (TSXV: $HIVE.V) Reports Q2 Results

 

 

Point Roberts, WA, Delta BC December 2, 2020 - Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving cryptocurrency stocks and the crypto market.

 

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2020/120220-CryptoMarket.mp3

 

Read this in full at

https://www.investorideas.com/news/2020/crypto-corner/12021Visa-HIVE.asp

 

Get the Crypto Corner Podcast on iTunes

 

Get the Crypto corner on Spotify

 

Stocks discussed: (NYSE:V) (TSXV:HIVE) (NasdaqGS:FB)

 

After recovering from last week’s brief slump and reclaiming a trading price around $19,000, Bitcoin (BTC) went on to even greater highs yesterday, recording a trading price of $19,837, according to data from CoinMarketCap. Other sources, such as CoinDesk, put the flagship crypto’s Tuesday peak at $19,920, which by many metrics makes for an all-time high trading price. Also according to CoinDesk, Tuesday saw an all-time high for recorded active user entities at 432,451, an increase of 70 percent from Bitcoin's halving on May 11 this year.

 

Bloomberg reports that Visa (NYSE:V) and crypto startup BlockFi are partnering to launch a credit card that offers Bitcoin as a reward for purchases. Specifically, users will accrue 1.5 percent of their purchases as Bitcoin rewards “and a lump sum $250 in the crypto-asset if they spend more than $3,000 in the first three months.” Zac Prince, Founder and CEO of BlockFi, said:

 

“We’re excited to add credit cards to our suite of products and expand Bitcoin’s accessibility to a broader set of consumers.”

 

HIVE Blockchain Technologies Ltd. (TSXV:HIVE) has reported its results for the second quarter ended September 30, 2020. Highlights include revenue from digital currency mining at $13 million, up 8 percent from the same quarter in 2019, and a record cash flow of $10.6 million, which is up from a loss of $4.6 million in the same quarter in 2019. The company’s Interim Executive Chairman, Frank Holmes, said:

 

"2020 has been marked by healthy expansion in mining capacity, the most recent example being HIVE's potential acquisition of a data center campus in Grand Falls, New Brunswick, that would give the company access to an additional 50 megawatts (MW) of low-cost green energy. Additionally, we recently locked in 50% of our energy costs for calendar 2021 at 1.6 cents per kilowatt hour in Sweden. This data point is one of the lowest in the blockchain mining ecosystem as well as in green energy.”

 

Libra, the digital currency project from Facebook (NasdaqGS:FB), has announced a change of its name to Diem, according to an official press release. Stuart Levey, the Diem Association’s CEO, explained:

 

“The Diem project will provide a simple platform for fintech innovation to thrive and enable consumers and businesses to conduct instantaneous, low-cost, highly secure transactions. We are committed to doing so in a way that promotes financial inclusion – expanding access to those who need it most, and simultaneously protecting the integrity of the financial system by deterring and detecting illicit conduct. We are excited to introduce Diem – a new name that signals the project’s growing maturity and independence.”

 

Sam Mowers, Investorideas

 

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

The Crypto Corner is part of the Investor Ideas Membership content

 

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

 

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

 

 

Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories 

#MedTech #Stocks in the News: Sigyn Therapeutics (OTC: $SIGY) Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma; @Sigyn_inc

#MedTech #Stocks in the News: Sigyn Therapeutics (OTC: $SIGY) Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma; @Sigyn_inc

 

SAN DIEGO, CA, December 2, 2020 / -(Investorideas.com newswire) Breaking Medical Tech/ therapeutic technology stock news -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on treating life-threatening inflammatory conditions, today announced the completion of an in vitro study that demonstrated the ability of Sigyn Therapy™ to clear both endotoxin and inflammatory cytokines from human blood plasma. 

 

Read this news featuring SIGY in full at https://www.investorideas.com/news/2020/biotech/12021Sigyn-Therapeutics-Endotoxin-Cytokines.asp

 

Sigyn Therapy is a novel blood purification technology designed to mitigate cytokine storm syndrome, which precipitates a wide-range of life-threatening conditions, including sepsis, the most common cause of hospital deaths.  Virus induced cytokine storm syndrome is associated with high mortality and currently is a leading cause of SARS-CoV-2 (COVID-19) deaths.  Sigyn Therapy is a single-use device designed for use on the established infrastructure of dialysis and CRRT machines located in hospitals and clinics worldwide.

 

In the in vitro study, Sigyn Therapy simultaneously reduced the presence of endotoxin and relevant pro-inflammatory cytokines, which included Interleukin-1 Beta (IL-1B), Interleukin-6 (IL-6) and Tumor Necrosis Factor alpha (TNF-a). Endotoxin (lipopolysaccharide or LPS) is a potent mediator implicated in the pathogenesis of sepsis and septic shock.  The dysregulated over-production of IL-1B, IL-6 and TNF-a can lead to organ failure and cause death.

 

An objective of the study was to rebalance elevated cytokine levels and optimize the elimination of endotoxin from human blood plasma. The study was conducted in triplicate over four-hour time periods with a pediatric version of Sigyn Therapy.  Average reduction of endotoxin load peaked at 83% during the studies. The average reduction of IL-1B was 69%, IL-6 reduction was 59% and TNF-a reduction was 57% during the four-hour studies.  The resulting data will be incorporated into an Investigational Device Exemption (IDE) that Sigyn plans to submit to the United States Food and Drug Administration (FDA) in 2021.

 

“The simultaneous clearance of endotoxin and inflammatory cytokines is a significant milestone that reinforces the potential of Sigyn Therapy to overcome the limitations of industry pioneering devices that are currently deployed to treat life-threatening inflammatory conditions,” stated Jim Joyce, Chairman and CEO of Sigyn Therapeutics.

 

At present, the CytoSorb device from CytoSorbents Corporation and the Toraymyxin device from Toray Industries are market cleared and broadly administered to treat a wide-range of life-threatening inflammatory conditions outside of the United States. In regards to mechanism, the Toraymyxin device has a high specificity to bind circulating endotoxin, but does not address inflammatory cytokines. Conversely, the CytoSorb device depletes inflammatory cytokines from circulation, but does not address endotoxin.

 

In addition to reporting the dual clearance of endotoxin and inflammatory cytokines, the Company further disclosed that it plans to evaluate the ability of Sigyn Therapy to address other inflammatory targets, including CytoVesicles that transport inflammatory cytokine cargos throughout the bloodstream.  The Company believes that Sigyn Therapy is the first therapeutic candidate to target circulating CytoVesicles.

 

About Sigyn Therapeutics

Sigyn Therapeutics™ is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

 

Sigyn Therapy™ is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

 

To learn more, visit www.SigynTherapeutics.com  or www.SigynTherapy.com

 

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements of Sigyn Therapeutics, Inc. (“Sigyn”) that involve substantial risks and uncertainties. All statements contained in this press release are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words “could,” “will,” “plan,” “intend,” “anticipate,” “approximate,” “expect,” “potential,” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among others, statements about Sigyn’s future financial performance, the impact of management changes, any proposed organizational restructuring, results of operations, capital resources to fund operations; statements about Sigyn’s expectations regarding the capitalization, resources and ownership structure of the combined company; statements about the potential benefits of the transaction; the expected completion and timing of the transaction and other information relating to the transaction; and any other statements other than statements of historical fact. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Sigyn makes due to a number of important factors, including (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect Sigyn’s business and the price of the common stock of Sigyn, (ii) the failure to satisfy of the conditions to the consummation of the transaction, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (iv) risks related to the ability to realize the anticipated benefits of the transaction, including the risk that the businesses will not be integrated successfully, (v) the effect of the announcement or pendency of the transaction on Sigyn’s business relationships, operating results and business generally, (vi) risks that the proposed transaction disrupts current plans and operations, (vii) risks related to the combined entity’s ability to up-list to a national securities exchange, (viii) risks related to the combined entity’s access to existing capital and fundraising prospects to fund its ongoing operations, (ix) risks related to diverting management’s attention from Sigyn’s ongoing business operations, (x) other business effects, including the effects of industry, market, economic, political or regulatory conditions, future exchange and interest rates, and changes in tax and other laws, regulations, rates and policies, and (xi) risks related to an inability to manufacture Sigyn Therapy, risks related to the clinical advancement of Sigyn Therapy with regulatory agencies, and no assurance that Sigyn Therapy will be proven to be a safe and efficacious treatment for any condition. The forward-looking statements in this press release represent Sigyn’s views as of the date of this press release. Sigyn anticipates that subsequent events and developments may cause its views to change. However, while it may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. You should, therefore, not rely on these forward-looking statements as representing Sigyn’s views as of any date subsequent to the date of this press release.

 

Contact Sigyn Therapeutics, Inc.

Jim Joyce

Chairman, CEO

(619) 368-2000

jimjoyce@elevatescience.com

 

Investorideas.com Paid news Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure : this news release featuring (OTCMARKETS: SIGY) is a paid for news release on Investorideas.com  https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

 

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on Investorideas.com

 

 

 

 

 

 

#Mining/ #Metals/ #GreenEnergy #Stock News -Defense Metals (TSX-V: $DEFN.V) (OTCQB: $DFMTF) Appoints Jamie Spratt as Strategic Advisor; @DefenseMetals

#Mining/ #Metals/ #GreenEnergy #Stock News -Defense Metals (TSX-V: $DEFN.V) (OTCQB: $DFMTF) Appoints Jamie Spratt as Strategic Advisor; @DefenseMetals

 

Vancouver, British Columbia –December 2, 2020: Investorideas.com Newswire  - Mining/Metals/ Green Energy Stock News Defense Metals Corp. (“Defense Metals”) (TSX-V:DEFN / OTCQB:DFMTF/ 35D: FSE) is pleased to announce the appointment of Mr. Jamie Spratt as a Strategic Advisor to the Company.

 

Read this news featuring DEFN in full at https://www.investorideas.com/news/2020/mining/12021DEFN-Jamie-Spratt.asp

 

Mr. Spratt is Principal at Walmsley Capital Inc., a focused mining corporate finance and advisory business that he founded in 2019. Over the past 14 years, Jamie has developed extensive mining capital markets and investment sector experience. He has built a strong reputation as an analyst and advisor having built deep partnerships with mining CEOs and institutional investors. Jamie was a Partner and Equity Research Analyst at Clarus Securities Inc., a small and mid capitalization focused boutique investment bank for 10 years, where he was instrumental in building one of the leading mining practices in Canada.

 

Based on his track record, Jamie became a highly rated mining analyst and attracted top institutional investors to many of his investment ideas. Jamie started his career in investment banking at an independent investment bank where he advised on M&A, merchant banking and corporate finance mandates primarily in the metals and mining sector and achieved valuable transaction experience. He has an MBA from the Rotman School of Management, a B.A. in Applied Economics from Queen's University and a CFA Charterholder. He is also a registered dealing representative at Belco Private Capital Inc., an exempt market dealer.

 

Craig Taylor, CEO comments:

 

"Mr. Spratt brings a wealth of corporate finance, capital markets, and M&A experience to bear on Defense Metals efforts to advance the Wicheeda REE Deposit. We look forward to Mr. Spratt's contributions in light of sustained upward price pressures on critical magnet metals, principally neodymium and praseodymium. Over the past six months we have seen an 80% increase in neodymium oxide spot prices from approximately USD$40/kg in early June to most recently USD$72/kg as of December 1, 20201. Defense Metals believes these price increases represent real future demand trends triggered as a result of the beginning of a fundamental shift towards the green energy-electric vehicle sector"

 

Wicheeda REE Project

The Wicheeda REE project has indicated mineral resources of 4,890,000 tonnes averaging 3.02% LREO (Light Rare Earth Elements) and inferred mineral resources of 12,100,000 tonnes averaging 2.90% LREO2.

 

Qualified Person

The scientific and technical information contained in this news release as it relates to the Wicheeda REE Property has been reviewed and approved by Kristopher J. Raffle, P.Geo. (BC) Principal and Consultant of APEX Geoscience Ltd. of Edmonton, AB, a director of Defense Metals and a "Qualified Person" as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

 

About Defense Metals Corp.

Defense Metals Corp. is a mineral exploration company focused on the acquisition of mineral deposits containing metals and elements commonly used in the electric power market, military, national security and the production of "GREEN" energy technologies, such as, high strength alloys and rare earth magnets. Defense Metals has an option to acquire 100% of the 1,708 hectare Wicheeda Rare Earth Element Property located near Prince George, British Columbia, Canada. Defense Metals Corp. trades in Canada under the symbol "DEFN" on the TSX Venture Exchange, in the United States, under "DFMTF" on the OTCQB and in Germany on the Frankfurt Exchange under "35D".

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

 

Cautionary Statement Regarding Forward Looking Information

This news release contains "forward–looking information or statements" within the meaning of applicable securities laws, which may include, without limitation, statements relating to the Company's plans for its Wicheeda project, the technical, financial and business prospects of the Company, its project and other matters. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of rare earth elements, the ability to achieve its goals, that general business and economic conditions will not change in a material adverse manner, that financing will be available if and when needed and on reasonable terms. Such forward-looking information reflects the Company's views with respect to future events and is subject to risks, uncertainties and assumptions, including those filed under the Company's profile on SEDAR at www.sedar.com. Factors that could cause actual results to differ materially from those in forward looking statements include, but are not limited to, continued availability of capital and financing and general economic, market or business conditions, adverse weather conditions, failure to maintain all necessary government permits, approvals and authorizations, failure to maintain community acceptance (including First Nations), decrease in the price of rare earth elements, the impact of Covid-19 or other viruses and diseases on the Company's ability to operate increase in costs, litigation, and failure of counterparties to perform their contractual obligations. The Company does not undertake to update forward–looking statements or forward–looking information, except as required by law.

 

1

 

Source: http://www.asianmetal.com accessed December 1, 2020

 

2

 

Technical Report on the Wicheeda Property, British Columbia, effective June 27, 2020 and prepared by APEX Geoscience Ltd. (Steven J. Nicholls, B.A. Sc., MAIG and Kristopher J. Raffle, B.Sc., P.Geo) is available under Defense Metals Corp.'s profile on SEDAR (www.sedar.com)

 

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Defense Metals Corp. is a paid for service  on Investorideas.com ($750) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

 

 

RenewableEnergyStocks.com: investing ideas in renewable energy stocks - solar, wind, batteries and more - Environmental, social and governance (ESG) investing tools

Like Renewable Energy Stocks? View our Renewable Energy Stocks Directory  

Get News Alerts on Renewable Energy Stocks  

 https://twitter.com/Investorideasc1

 

MiningSectorStocks.com - investing ideas in mining stocks

Like Mining Stocks? View our Mining Stocks Directory